Korostin Dmitriy Olegovich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Korostin Dmitriy Olegovich has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Anna Yurievna Krasnenko
Genotek Ltd, Nastavnicheskii pereulok 17/1, 105120 Moscow, Russia
1 shared publication - Davidova Anna Igorevna
Institute of Gene Biology, Vavilova street 34/5, 119334 Moscow, Russia
1 shared publication - Ekaterina Vladimirovna Semina
Russian Mental Health Research Center, Kashirskoe Sh., 34, Moscow 115522, Russia
1 shared publication - Kirill Tsukanov
Genotek Ltd., Moscow, Russia
1 shared publication - Olesia Igorevna Klimchuk
Genotek Ltd., Moscow, Russia
1 shared publication - Olga Borisovna Kondakova
National Medical Research Center for Children’s Health
1 shared publication
Latest Publications
- Open Access
- 8 April 2019
- Published by Springer Nature in BMC Pediatrics
- Vol. 19 (1) , 98
Compound heterozygous POMGNT1 mutations leading to muscular dystrophy-dystroglycanopathy type A3: a case report
Dystroglycanopathies, which are caused by reduced glycosylation of alpha-dystroglycan, are a heterogeneous group of neurodegenerative disorders characterized by variable brain and skeletal muscle involvement. Muscle-eye-brain disease (or muscular dystrophy-dystroglycanopathy type 3 A) is an autosomal recessive disorder characterized by congenital muscular dystrophy, ocular abnormalities, and lissencephaly. We report clinical and genetic characteristics of a 6-year-old boy affected by muscular dystrophy-dystroglycanopathy. He has severe a delay in psychomotor and speech development, muscle hypotony, congenital myopia, partial atrophy of the optic nerve disc, increased level of creatine kinase, primary-muscle lesion, polymicrogyria, ventriculomegaly, hypoplasia of the corpus callosum, cysts of the cerebellum. Exome sequencing revealed compound heterozygous mutations in POMGNT1 gene (transcript NM_001243766.1): c.1539 + 1G > A and c.385C > T. The present case report shows diagnostic algorithm step by step and helps better understand the clinical and genetic features of congenital muscular dystrophy.
- 8 April 2019
- Published by Springer Nature in BMC Pediatrics
- Vol. 19 (1) , 98
Open AccessCompound heterozygous POMGNT1 mutations leading to muscular dystrophy-dystroglycanopathy type A3: a case report
Dystroglycanopathies, which are caused by reduced glycosylation of alpha-dystroglycan, are a heterogeneous group of neurodegenerative disorders characterized by variable brain and skeletal muscle involvement. Muscle-eye-brain disease (or muscular dystrophy-dystroglycanopathy type 3 A) is an autosomal recessive disorder characterized by congenital muscular dystrophy, ocular abnormalities, and lissencephaly. We report clinical and genetic characteristics of a 6-year-old boy affected by muscular dystrophy-dystroglycanopathy. He has severe a delay in psychomotor and speech development, muscle hypotony, congenital myopia, partial atrophy of the optic nerve disc, increased level of creatine kinase, primary-muscle lesion, polymicrogyria, ventriculomegaly, hypoplasia of the corpus callosum, cysts of the cerebellum. Exome sequencing revealed compound heterozygous mutations in POMGNT1 gene (transcript NM_001243766.1): c.1539 + 1G > A and c.385C > T. The present case report shows diagnostic algorithm step by step and helps better understand the clinical and genetic features of congenital muscular dystrophy.